Kory James Wentworth

Chief Financial Officer

Chief Financial Officer at Entrada Therapeutics, Inc., filing insider transactions between 2026-03-04 and 2026-04-01.

Total Purchases

—

0 transactions

Total Sales

$345K

4 transactions

Companies Traded

4 total filings

Active Since

2026-03-04

Last: 2026-04-01

Companies

Entrada Therapeutics, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-04-01	TRDA	Sale	2,500	$12.95	$32K	119.0K	SEC ↗
2026-03-10	TRDA	Sale	11.4K	$13.02	$148K	121.5K	SEC ↗
2026-03-09	TRDA	Sale	5,089	$13.00	$66K	132.9K